Current Infectious Disease Reports

Scope & Guideline

Elevating the Standard of Infectious Disease Reporting

Introduction

Immerse yourself in the scholarly insights of Current Infectious Disease Reports with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1523-3847
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationCURR INFECT DIS REP / Curr. Infect. Dis. Rep.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

Current Infectious Disease Reports focuses on the dissemination of knowledge related to infectious diseases, emphasizing clinical, epidemiological, and therapeutic advancements. The journal aims to bridge the gap between research and practice, providing insights that impact patient care and public health strategies.
  1. Infectious Disease Epidemiology:
    The journal covers trends, outbreaks, and epidemiological studies related to various infectious diseases, helping to understand their spread and impact on populations.
  2. Clinical Management and Therapeutics:
    It emphasizes advancements in treatment strategies, including novel therapies and management protocols for infectious diseases, ensuring practitioners are informed about the latest clinical guidelines.
  3. Antimicrobial Stewardship and Resistance:
    A core focus is on antimicrobial resistance, exploring stewardship practices, resistance patterns, and the development of new therapeutic agents to combat resistant infections.
  4. Infection Prevention and Control:
    The journal provides insights into best practices for infection prevention in various settings, highlighting innovative approaches to reduce healthcare-associated infections.
  5. Global Health Perspectives:
    It addresses infectious diseases from a global perspective, emphasizing challenges faced in low- and middle-income countries, and the impact of social determinants on health.
Current Infectious Disease Reports has increasingly focused on emerging and re-emerging infectious diseases, reflecting the dynamic nature of global health challenges. Several themes have gained attention, indicating new research priorities.
  1. Emerging Viral Infections:
    A significant uptick in research addressing emerging viruses such as MPox and Marburg highlights the journal's commitment to understanding and managing new health threats.
  2. Impact of Climate Change on Infectious Diseases:
    Recent publications exploring the relationship between climate change and infectious disease outbreaks indicate an emerging focus on environmental health and its implications for infectious disease epidemiology.
  3. Invasive Fungal Infections:
    There is a growing interest in the management and treatment of invasive fungal infections, particularly in immunocompromised populations, reflecting broader concerns about fungal resistance and diagnostics.
  4. Artificial Intelligence in Infection Management:
    The integration of AI and advanced technologies in managing and predicting infectious disease outcomes is gaining traction, showcasing the journal's openness to innovative approaches.
  5. Antimicrobial Resistance and New Therapeutics:
    Research on antimicrobial resistance remains a priority, with an increased emphasis on developing new therapeutic agents and strategies to combat resistant infections.

Declining or Waning

While Current Infectious Disease Reports continues to evolve, certain themes have shown a decline in prominence over recent years. This may reflect shifting research priorities or changing public health needs.
  1. Traditional Antiviral Therapies:
    There is a noticeable decrease in publications focused on conventional antiviral medications, possibly due to the rise of novel therapies and the urgency of addressing emerging viruses.
  2. General Pediatric Infectious Diseases:
    Research specifically addressing common pediatric infections appears to be waning, as the focus has shifted towards more complex cases and emerging threats in pediatric populations.
  3. Surgical Infections and Postoperative Complications:
    The frequency of articles detailing traditional surgical site infections and management strategies has declined, indicating a potential shift towards more innovative or preventive approaches.
  4. Travel-related Infectious Diseases:
    While still relevant, the volume of articles specifically addressing travel-related infections has decreased, perhaps due to changes in travel patterns and public health responses to recent pandemics.
  5. Non-Communicable Diseases Related to Infectious Agents:
    Research linking infectious diseases to non-communicable diseases (e.g., cancers related to viral infections) has seen less focus, possibly overshadowed by more immediate infectious disease challenges.

Similar Journals

Journal of Pathogens

Transforming Insights into Actionable Knowledge
Publisher: HINDAWI LTDISSN: 2090-3057Frequency:

Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

BMC INFECTIOUS DISEASES

Championing open access to vital infectious disease research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Infectious Diseases is a premier open-access journal published by BMC in the United Kingdom, dedicated to the field of infectious diseases. Established in 2001, this journal has been at the forefront of disseminating high-quality, peer-reviewed research, contributing significantly to the global understanding of infectious pathogens and their impact on public health. With a 2023 Scopus ranking of #100 out of 344 in the Medicine - Infectious Diseases category, and a notable Q1 quartile classification, it stands as a vital resource for researchers and professionals alike. Authors benefit from the journal's broad reach and visibility, ensuring their work is accessible to a wide audience. Access options are fully open, allowing for seamless dissemination of knowledge in the ongoing battle against infectious diseases. With an established history of publishing groundbreaking studies, BMC Infectious Diseases plays a crucial role in addressing critical issues and advancing research in the ever-evolving landscape of infectious diseases.

Infection and Chemotherapy

Advancing the Fight Against Infection and Disease
Publisher: KOREAN SOC ANTIMICROBIAL THERAPYISSN: 2093-2340Frequency: 4 issues/year

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

AMERICAN JOURNAL OF INFECTION CONTROL

Innovating strategies for infection control excellence.
Publisher: MOSBY-ELSEVIERISSN: 0196-6553Frequency: 10 issues/year

The American Journal of Infection Control is a leading peer-reviewed publication dedicated to advancing the field of infection prevention and control. Published by Mosby-Elsevier, this journal has been a crucial resource since its inception in 1980, focusing on the intersection of infectious diseases, public health, and health policy. As of 2023, it holds an impressive Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health, while also achieving Q2 rankings in Epidemiology and Infectious Diseases. With an increasing impact factor and a strong reputation reflected in its Scopus rankings, the journal appeals to researchers, health professionals, and students committed to preventing the spread of infections and enhancing healthcare safety. Although it does not currently offer Open Access, the journal ensures broad dissemination of its vital research through various subscription options. By fostering interdisciplinary collaboration and evidence-based practices, the American Journal of Infection Control plays a pivotal role in shaping effective infection control policies and practices worldwide.

JOURNAL OF INFECTION

Connecting Researchers and Clinicians in Infection Science
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

New Microbes and New Infections

Pioneering research on emerging microbes and infections.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Infektsiya i Immunitet

Empowering research to combat infectious challenges.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

Brazilian Journal of Infectious Diseases

Elevating the discourse on infectious diseases globally.
Publisher: ELSEVIER BRAZILISSN: 1413-8670Frequency: 6 issues/year

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

JOURNAL OF INFECTION AND CHEMOTHERAPY

Connecting Researchers for Global Health Impact
Publisher: ELSEVIERISSN: 1341-321XFrequency: 6 issues/year

JOURNAL OF INFECTION AND CHEMOTHERAPY, published by Elsevier, is a leading journal in the fields of Infectious Diseases, Microbiology, and Pharmacology. With a solid reputation reflected in its prestigious Q2 ranking in Infectious Diseases and Pharmacology, and Q3 in Microbiology (medical), this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and prevention of infectious diseases. The journal provides a platform for high-quality, peer-reviewed scholarly articles, making it an essential reference point in the medical community. Despite being published without open access, it continues to attract significant scholarly attention, as denoted by its rankings in Scopus, which showcases its impact within the academic landscape. With a timeline converging from 1995 to 2024, JOURNAL OF INFECTION AND CHEMOTHERAPY is dedicated to advancing knowledge and contributing to better health outcomes globally.

LANCET INFECTIOUS DISEASES

Transforming Knowledge into Public Health Solutions
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.